Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124914032 | 12491403 | 2 | F | 2014 | 20160705 | 20160623 | 20160711 | EXP | RU-UCBSA-2016022902 | UCB | 8.00 | YR | F | Y | 36.00000 | KG | 20160711 | MD | RU | RU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124914032 | 12491403 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | 2000 MG, KEPPRADAY 2 ADMISSION | U | U | 21035 | FILM-COATED TABLET | ||||||||
| 124914032 | 12491403 | 2 | C | CLONAZEPAM. | CLONAZEPAM | 1 | U | U | 0 | ||||||||||
| 124914032 | 12491403 | 3 | C | VALPROIC ACID. | VALPROIC ACID | 1 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124914032 | 12491403 | 1 | Partial seizures |
| 124914032 | 12491403 | 2 | Product used for unknown indication |
| 124914032 | 12491403 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124914032 | 12491403 | HO |
| 124914032 | 12491403 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124914032 | 12491403 | Atrial fibrillation | |
| 124914032 | 12491403 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |